Theradiag 2020 Revenues up 8 Percent
The French firm attributed the revenue increase to strong sales of its theranostics products, which include its therapeutic drug monitoring tests.
Startup Coral Genomics Wins $2M SBIR Grant From NIH
The funding will help the San Francisco-based firm apply low-depth NGS as it builds diagnostic tests to aid therapy selection in more diverse populations.
BioSequence is looking to raise the profile of its genomic offering among clinicians, and to strengthen its case for reimbursement.
Theradiag Partners with French Institutions for Rheumatoid Arthritis Dx Tools
NEW YORK (GenomeWeb News) – Diagnostic firm Theradiag today announced a partnership with French organizations to develop diagnostic and theranostic tools for rheumatoid arthritis.
First Test Launched, Theranostics Focuses on Reimbursements as it Builds Commercial Operations
NEW YORK (GenomeWeb News) – Months removed from the commercial launch of its first test, Theranostics Health is targeting reimbursements as it looks to build a revenue stream for the test.
Nov 14, 2012
Alacris, GSK Ink Cancer Drug Stratification Deal
Jun 27, 2012
Theradiag Acquires miRNA Firm Prestizia
Apr 21, 2010
R&D Antibodies Gets $2.6M Grant for Sepsis Test
Oct 15, 2009
Pikamab Obtains Lupus Theranostic IP from NY's HSS
Oct 6, 2009